BAKER BROS. ADVISORS LP 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-10 4:42 pm Sale | 2023-07-31 | 13G | Mereo BioPharma Group plc MREO | BAKER BROS. ADVISORS LP | 14,604,391 2.200% | -54,754,968 (-78.94%) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | BAKER BROS. ADVISORS LP | 69,359,359 9.990% | 4,441,758 (+6.84%) | Filing |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | BAKER BROS. ADVISORS LP | 64,917,601 9.990% | 25,285,672 (+63.80%) | Filing |
| 2021-02-16 4:53 pm Purchase | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | BAKER BROS. ADVISORS LP | 39,631,929 11.400% | 39,631,929 (New Position) | Filing |